MedTrace Logo

A Study to Learn About the Study Medicine Zavicefta After it is Released Into the Markets in Korea

NCT05733104 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2025-09-03

No results posted yet for this study

Summary

The purpose of this study is to learn about the safety and effectiveness of Zavicefta once released into the markets in Korea. This study is to learn about Zavicefta in patients with difficult types of infections in the abdomen, urinary tract and pneumonia which could have come from hospitalizations.

This study was required by the Ministry of Food and Drug Safety (MFDS) of Korea's regulations.

Conditions

  • Complicated Intra-abdominal Infection
  • Complicated Urinary Tract Infection
  • Hospital-acquired Pneumonia

Sponsors & Collaborators

Principal Investigators

  • Pfizer CT.gov Call Center · Pfizer

Eligibility

Min Age
3 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-02-19
Primary Completion
2029-09-28
Completion
2029-09-28

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05733104 on ClinicalTrials.gov